Compare CLDX & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLDX | HP |
|---|---|---|
| Founded | N/A | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 1995 | 1994 |
| Metric | CLDX | HP |
|---|---|---|
| Price | $28.36 | $34.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 17 |
| Target Price | ★ $63.07 | $45.44 |
| AVG Volume (30 Days) | 1.1M | ★ 1.2M |
| Earning Date | 11-17-2026 | 11-19-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $12,743,000.00 | ★ $3,746,013,000.00 |
| Revenue This Year | $19.74 | $8.38 |
| Revenue Next Year | $373.52 | $5.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 87.78 | 35.89 |
| 52 Week Low | $22.10 | $24.45 |
| 52 Week High | $45.14 | $48.17 |
| Indicator | CLDX | HP |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 38.54 |
| Support Level | $28.34 | $36.11 |
| Resistance Level | $31.47 | $36.56 |
| Average True Range (ATR) | 1.35 | 1.86 |
| MACD | 0.35 | -0.11 |
| Stochastic Oscillator | 71.35 | 14.81 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.